Back to Explorer

CVM GFI #221 Recommendations for Preparation and Submission of Animal Food Additive Petitions

FinalCenter for Veterinary Medicine06/12/2015

Description

FDA regulates foods and substances added to food under the Federal Food, Drug, and Cosmetic Act (FD&C Act). Many substances added to foods are food additives. Section 201(s) of the FD&C Act (21 U.S.C. § 321(s)) defines a “food additive” as “any substance the intended use of which results or may reasonably be expected to result, directly or indirectly, in its becoming a component of or otherwise affecting the characteristics of any food.” Section 201(s) excludes from this definition any substance that is generally recognized as safe (GRAS) among qualified experts under the conditions of its intended use, or that qualifies for any of the other exemptions from the food additive definition (e.g., new animal drug, color additive, etc.).

Scope & Applicability

Product Classes

3
Animal Food Additive

Substances added to animal food requiring approval

Veterinary Pharmaceutical Products

Target Animal Safety for Veterinary Pharmaceutical Products

Food Additive

Approved substances for direct addition to food

Stakeholders

3
Petitioner

Party submitting a citizen petition; party evaluating whether a food allergen is of public health importance; Party recommended to conduct systematic reviews and evidence scoring.

Division of Animal Feeds

CVM division for pre-petition consultations

Sponsor

Entity responsible for submitting applications under section 524B

Regulatory Context

Attributes

3
Shelf life

Determined by the sponsor for the investigational product.; investigational product(s) are stable over the period of use and only used within the current shelf life

Microbiological ADI

Acceptable daily intake established for antimicrobial residues; General approach to establish a microbiological Acceptable Daily Intake; An ADI established on the basis of microbiological data

Expiration date

should be based on appropriate supportive stability data

Identified Hazards

Hazards

3
Reaction byproducts

Impurities that must be limited in specifications

Serious harm to the environment

Extraordinary circumstance for environmental review

Antimicrobial Resistance

Public health threat resulting from loss of effectiveness of antimicrobial therapies; Efforts to mitigate the development of antimicrobial resistance.; Public health concern that labeling changes aim to mitigate.; development and spread of antimicrobial resistance encouraged by certain practices

Related CFR Sections (9)

Related Warning Letters (10)

  • Good Laboratory Practice (GLP) for Nonclinical Laboratory Studies

    CCIC Huatongwei International Inspection Co., Ltd.

    2025-08-26
  • Good Laboratory Practice (GLP) for Nonclinical Laboratory Studies

    Jiangsu Kerbio Medical Technology Group Co.

    2025-08-26
  • Unapproved New Animal Drug Products

    Holista LLC dba HolistaPet

    2025-04-29
  • Unapproved New Animal Drug Products

    Bailey’s Wellness, LLC dba Bailey’s CBD

    2025-04-29
  • Investigational Device Exemptions (IDE)/Premarket Approval Application (PMA)

    Mid-Link Testing Company, Ltd

    2024-09-11
  • Investigational Device Exemptions (IDE)/Premarket Approval Application (PMA)

    Sanitation & Environmental Technology Institute dba SDWH

    2024-09-11
  • Good Laboratory Practice (GLP) for Nonclinical Laboratory Studies

    Samm Solutions, Inc., d.b.a. BTS Research

    2023-10-31
  • Unapproved New Drugs/Misbranded/Cannabidiol (CBD) Products

    Infusionz, LLC

    2022-11-21
  • Bioresearch Monitoring Program

    Valley Biosystems

    2022-08-09
  • Unapproved New Drugs/Misbranded/Cannabidiol (CBD) Products

    Plantacea, LLC dba Kahm

    2022-05-26

See Also (8)

CVM GFI #221 Recommendations for Preparation and Submission of Animal Food Additive Petitions | Guideline Explorer | BioRegHub